Andrew Bolt
Directeur Général chez SphynKx Therapeutics LLC
Provenance du réseau au premier degré de Andrew Bolt
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
SphynKx Therapeutics LLC
 SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology SphynKx Therapeutics LLC engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis. Its Sphingosine 1-phosphate (S1P) is recognized as a key regulator of many of the cellular processes that promote wound healing and fibrogenesis, which include fibroblast and immune cell migration, vascular leak, proliferation, angiogenesis, and TGF-ß signaling. The company was founded by Andrew Bolt, Kevin R. Lynch, Webster Santos and Timothy L. Macdonald in 2010 and is headquartered in Charlottesville, VA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Andrew Bolt via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Virginia | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co. LLC is a venture capital firm founded by Lawrence Miller and Paul Howard in 1999. It is headquartered in Newton, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Pharmaceuticals: Major | Founder | |
| University of Rhode Island | College/University | Doctorate Degree | |
| The University of Virginia School of Medicine | College/University | Director/Board Member | |
Continuum Biosciences, Inc.
 Continuum Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 10 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Founder | 6 |
| Director/Board Member | 5 |
| Doctorate Degree | 3 |
| Undergraduate Degree | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Timothy L. MacDonald | 8 |
| Kevin R. Lynch | 5 |
| Webster Santos | 3 |
- Bourse
- Insiders
- Andrew Bolt
- Connexions Sociétés
